Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > PFIZER - CHINA DEAL, LABS - NEW CLASS OF CANCER KILLERS
View:
Post by subaru1i on Mar 27, 2023 9:55am

PFIZER - CHINA DEAL, LABS - NEW CLASS OF CANCER KILLERS

PFIZER - LABS = $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

'traditional global pharmaceutical partner',  David Pidduck, CEO of LABS
Comment by subaru1i on Mar 27, 2023 10:00am
https://www.msn.com/en-ca/money/companies/pfizer-signs-agreement-with-china-on-improving-health-coverage-in-the-country/ar-AA196QWl?ocid=msedgntp&cvid=34cfc5c5d60d47d580c086b55e03e5b8&ei=65 Pfizer signs agreement with China on improving health coverage in the country Story by Evelyn Cheng • Yesterday 10:47 p.m.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities